Ключевые слова
atorvastatin; beta 1 adrenergic receptor blocking agent; C reactive protein; carbazole derivative; carvedilol; heptanoic acid derivative; hypocholesterolemic agent; interleukin 6; metoprolol; propanolamine derivative; pyrrole derivative; tumor necrosis factor alpha; adult; aged; arteriole; article; blood pressure; chronic disease; clinical trial; controlled clinical trial; controlled study; drug combination; drug effect; elasticity; female; heart failure; heart muscle ischemia; heart stroke volume; human; male; metabolism; middle aged; pathology; pathophysiology; randomized controlled trial; treatment outcome; vascular resistance; Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Anticholesteremic Agents; Arterioles; Blood Pressure; C-Reactive Protein; Carbazoles; Chronic Disease; Drug Therapy, Combination; Elasticity; Female; Heart Failure; Heptanoic Acids; Humans; Interleukin-6; Male; Metoprolol; Middle Aged; Myocardial Ischemia; Propanolamines; Pyrroles; Stroke Volume; Treatment Outcome; Tumor Necrosis Factor-alpha; Vascular Resistance